Clinical Trial

Heparin-binding Protein and Lungedema in ICU Patients.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this single center observational cohort study is to investigate the relationship between physiological measures of lung oedema, and the biomarker Heparin-binding Protein (HBP). The main questions it aims to answer are: * Does the concentration of HBP in plasma correlate with measures of lung vascular permeability and extravascular water in the lungs? * Does the concentration of HBP in plasma correlate with the patient's total accumulated fluid balance? Researchers will collect blood samples and gather information on lung vascular permeability and extravascular lung water in Intensive care patients who are provided with a hemodynamic surveillance system called PiCCO. The study will include 25 patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-19.
Trial Details
NCT Number NCT07434908
Lead Sponsor Umeå University
Conditions Lung Edema
Enrollment 25 participants
Start Date 2024-05-06
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-10